Product Revenue, Net - Schedule of Revenue from Customers as a Percentage of Total Product Revenue, Net (Details) - Gross product revenue - Customer	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Cardinal Health
Disaggregation of Revenue [Line Items]
Concentration risk (percent)	22.40%	22.70%	22.30%	21.70%
AmerisourceBergen Drug Corporation
Disaggregation of Revenue [Line Items]
Concentration risk (percent)	21.10%	40.20%	21.30%	35.10%
McKesson Corporation
Disaggregation of Revenue [Line Items]
Concentration risk (percent)	18.40%	24.60%	19.40%	22.50%
BioRidge Pharma, LLC
Disaggregation of Revenue [Line Items]
Concentration risk (percent)	20.00%	0.00%	19.00%	0.00%